Table 3.
Air pollutants | Inflammatory protein | Lung function and CRDs associated with exposures | OR (95%CI) | p-value |
---|---|---|---|---|
OR (95%CI), p-value as outcome associated with air pollutants | ||||
PM2.5 | Interleukin-2 0.596 (0.436–0.816) p = 0.001** |
FEV1 | 0.998 (0.978–1.019) | 0.876 |
COPD | 1.001 (0.936–1.069) | 0.996 | ||
Neurotrophin-3 0.697 (0.529–0.920) p = 0.011* |
FEV1 | 1.004 (0.984–1.025) | 0.693 | |
COPD | 1.030 (0.966–1.098) | 0.374 | ||
PM10 | Axin-1 0.840 (0.707–0.998) p = 0.048* |
FEV1 | 0.968 (0.946–0.990) | 0.005** |
FVC | 0.987 (0.964–1.010) | 0.267 | ||
FEV1/FVC | 0.961 (0.939–0.984) | 0.001** | ||
Natural killer cell receptor 2B4 0.809 (0.694–0.944) p = 0.007** |
FEV1 | 0.995 (0.978–1.012) | 0.554 | |
FVC | 0.996 (0.979–1.013) | 0.644 | ||
FEV1/FVC | 0.990 (0.974–1.006) | 0.234 | ||
CD40L receptor 0.808 (0.694–0.940) p = 0.006** |
FEV1 | 1.001 (0.990–1.011) | 0.933 | |
FVC | 0.996 (0.986–1.007) | 0.513 | ||
FEV1/FVC | 1.003 (0.993–1.013) | 0.541 | ||
U-cell surface glycoprotein CD6 isoform 0.830 (0.710–0.969) p = 0.018* |
FEV1 | 0.998 (0.990–1.006) | 0.651 | |
FVC | 1.001 (0.992–1.009) | 0.936 | ||
FEV1/FVC | 0.991 (0.983–0.999) | 0.041* | ||
Interleukin-17A 1.335 (1.123–1.587) p = 0.001** |
FEV1 | 0.966 (0.946–0.987) | 0.001** | |
FVC | 0.968 (0.9470.991) | 0.005** | ||
FEV1/FVC | 0.998 (0.977–1.018) | 0.817 | ||
Interleukin-33 0.801 (0.674–0.952 P = 0.01*) |
FEV1 | 1.018 (0.995–1.042) | 0.130 | |
FVC | 1.028 (1.005–1.052) | 0.018* | ||
FEV1/FVC | 0.984 (0.957–1.011) | 0.248 | ||
STAM binding protein 0.827 (0.708–0.966) p = 0.016* |
FEV1 | 0.999 (0.972–1.027) | 0.953 | |
FVC | 0.999 (0.973–1.028) | 0.994 | ||
FEV1/FVC | 0.999 (0.971–1.027) | 0.922 | ||
NO2 | Matrix metalloproteinase-10 1.436 (1.134–1.819) p = 0.003** |
COPD | 1.005 (0.971–1.040) | 0.774 |
FEV1/FVC | 0.998 (0.980–1.017) | 0.826 |
PM, particulate matter; NO2, nitrogen oxides; FEV1, forced expiratory volume in one second; FVC, forced vital capacity; CRDs, chronic respiratory disease; COPD, chronic obstructive pulmonary disease; IPF, idiopathic pulmonary fibrosis; *p < 0.05; **p < 0.01.